Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects

Lenharo, M. WHO declares end to COVID-19’s emergency phase. Nature, 2023, 01559.
[http://dx.doi.org/10.1038/d41586-023-01559-z] [PMID: 37147368]

Vilches, TN; Sah, P; Moghadas, SM; Shoukat, A; Fitzpatrick, MC; Hotez, PJ; Schneider, EC; Galvani, AP COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA. Lancet Reg. Heal Am., 2022, 6, 100147.

The Lancet. The COVID-19 pandemic in 2023: Far from over. Lancet, 2023, 401(10371), 79.
[http://dx.doi.org/10.1016/S0140-6736(23)00050-8] [PMID: 36641201]

Booth, A.; Reed, A.B.; Ponzo, S.; Yassaee, A.; Aral, M.; Plans, D.; Labrique, A.; Mohan, D. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One, 2021, 16(3), e0247461.
[http://dx.doi.org/10.1371/journal.pone.0247461] [PMID: 33661992]

Ryan, P.M.; Caplice, N.M. Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019? Obesity, 2020, 28(7), 1191-1194.
[http://dx.doi.org/10.1002/oby.22843] [PMID: 32314868]

Tamara, A.; Tahapary, D.L. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes Metab. Syndr., 2020, 14(4), 655-659.
[http://dx.doi.org/10.1016/j.dsx.2020.05.020] [PMID: 32438328]

Kassir, R. Risk of COVID‐19 for patients with obesity. Obes. Rev., 2020, 21, e13034.

William, D. Obesity and its implications for COVID-19 mortality. Obesity, 2020, 28, 1005-1005.
[http://dx.doi.org/10.1002/oby.22818] [PMID: 32237206]

Gerhart, J.G.; Balevic, S.; Sinha, J.; Perrin, E.M.; Wang, J.; Edginton, A.N.; Gonzalez, D. Characterizing pharmacokinetics in children with obesity-physiological, drug, patient, and methodological considerations. Front. Pharmacol., 2022, 13, 818726.
[http://dx.doi.org/10.3389/fphar.2022.818726] [PMID: 35359853]

Smit, C.; De Hoogd, S.; Brüggemann, R.J.M.; Knibbe, C.A.J. Obesity and drug pharmacology: A review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters. Expert Opin. Drug Metab. Toxicol., 2018, 14(3), 275-285.
[http://dx.doi.org/10.1080/17425255.2018.1440287] [PMID: 29431542]

Barras, M.; Legg, A. Drug dosing in obese adults. Aust. Prescr., 2017, 40(5), 189-193.
[http://dx.doi.org/10.18773/austprescr.2017.053] [PMID: 29109603]

Han, P.Y.; Duffull, S.B.; Kirkpatrick, C.M.J.; Green, B. Dosing in obesity: A simple solution to a big problem. Clin. Pharmacol. Ther., 2007, 82(5), 505-508.
[http://dx.doi.org/10.1038/sj.clpt.6100381] [PMID: 17952107]

Morrish, G.A.; Pai, M.P.; Green, B. The effects of obesity on drug pharmacokinetics in humans. Expert Opin. Drug Metab. Toxicol., 2011, 7(6), 697-706.
[http://dx.doi.org/10.1517/17425255.2011.570331] [PMID: 21417960]

Nwabufo, C.K.; Bendayan, R. Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. Trends Pharmacol. Sci., 2022, 43(12), 1041-1054.
[http://dx.doi.org/10.1016/j.tips.2022.09.005] [PMID: 36374805]

Goldman, J.D.; Lye, D.C.B.; Hui, D.S.; Marks, K.M.; Bruno, R.; Montejano, R.; Spinner, C.D.; Galli, M.; Ahn, M.Y.; Nahass, R.G.; Chen, Y.S.; SenGupta, D.; Hyland, R.H.; Osinusi, A.O.; Cao, H.; Blair, C.; Wei, X.; Gaggar, A.; Brainard, D.M.; Towner, W.J.; Muñoz, J.; Mullane, K.M.; Marty, F.M.; Tashima, K.T.; Diaz, G.; Subramanian, A. Remdesivir for 5 or 10 days in patients with severe Covid-19. N. Engl. J. Med., 2020, 383(19), 1827-1837.
[http://dx.doi.org/10.1056/NEJMoa2015301] [PMID: 32459919]

Wang, Y.; Zhang, D.; Du, G.; Du, R.; Zhao, J.; Jin, Y.; Fu, S.; Gao, L.; Cheng, Z.; Lu, Q.; Hu, Y.; Luo, G.; Wang, K.; Lu, Y.; Li, H.; Wang, S.; Ruan, S.; Yang, C.; Mei, C.; Wang, Y.; Ding, D.; Wu, F.; Tang, X.; Ye, X.; Ye, Y.; Liu, B.; Yang, J.; Yin, W.; Wang, A.; Fan, G.; Zhou, F.; Liu, Z.; Gu, X.; Xu, J.; Shang, L.; Zhang, Y.; Cao, L.; Guo, T.; Wan, Y.; Qin, H.; Jiang, Y.; Jaki, T.; Hayden, F.G.; Horby, P.W.; Cao, B.; Wang, C. Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial. Lancet, 2020, 395(10236), 1569-1578.
[http://dx.doi.org/10.1016/S0140-6736(20)31022-9] [PMID: 32423584]

Shargel, L.; Wu-Pong, S.; Yu, A.B.C. Introduction to biopharmaceutics and pharmacokinetics. In: Applied Biopharmaceutics; The McGraw-Hill Companies: New York, NY, 2012.

Saadeh, S. Nonalcoholic Fatty liver disease and obesity. Nutr. Clin. Pract., 2007, 22(1), 1-10.
[http://dx.doi.org/10.1177/011542650702200101] [PMID: 17242448]

Elfiky, A.A. Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci., 2020, 253, 117592.
[http://dx.doi.org/10.1016/j.lfs.2020.117592] [PMID: 32222463]

Adeoye, A.O.; Oso, B.J.; Olaoye, I.F.; Tijjani, H.; Adebayo, A.I. Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. J. Biomol. Struct. Dyn., 2020, 1-11.
[PMID: 32375574]

Jain, M.K.; Zoellner, C. Role of ribavirin in HCV treatment response: Now and in the future. Expert Opin. Pharmacother., 2010, 11(4), 673-683.
[http://dx.doi.org/10.1517/14656560903580001] [PMID: 20163278]

Jácome, R.; Campillo-Balderas, J.A.; Ponce de León, S.; Becerra, A.; Lazcano, A. Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic. Sci. Rep., 2020, 10(1), 9294.
[http://dx.doi.org/10.1038/s41598-020-66440-9] [PMID: 32518317]

Kirby, B.J.; Symonds, W.T.; Kearney, B.P.; Mathias, A.A. Pharmacokinetic, pharmacodynamic, and drug-interaction profile of the hepatitis C Virus NS5B polymerase inhibitor sofosbuvir. Clin. Pharmacokinet., 2015, 54(7), 677-690.
[http://dx.doi.org/10.1007/s40262-015-0261-7] [PMID: 25822283]

Mogalian, E.; Brainard, D.M.; Osinusi, A.; Moorehead, L.; Murray, B.; Ling, K.H.J.; Perry, R.; Curtis, C.; Lawitz, E.; Lasseter, K.; Marbury, T.; Mathias, A. Pharmacokinetics and safety of velpatasvir and sofosbuvir/velpatasvir in subjects with hepatic impairment. Clin. Pharmacokinet., 2018, 57(11), 1449-1457.
[http://dx.doi.org/10.1007/s40262-018-0645-6] [PMID: 29520729]

Salvi, R.; Patankar, P. Emerging pharmacotherapies for COVID-19. Biomed. Pharmacother., 2020, 128, 110267.
[http://dx.doi.org/10.1016/j.biopha.2020.110267] [PMID: 32410772]

Jain, R.; Chung, S.M.; Jain, L.; Khurana, M.; Lau, S.W.J.; Lee, J.E.; Vaidyanathan, J.; Zadezensky, I.; Choe, S.; Sahajwalla, C.G. Implications of obesity for drug therapy: Limitations and challenges. Clin. Pharmacol. Ther., 2011, 90(1), 77-89.
[http://dx.doi.org/10.1038/clpt.2011.104] [PMID: 21633345]

Leden, I. Digoxin-hydroxychloroquine interaction? Acta Med. Scand., 1982, 211(5), 411-412.
[http://dx.doi.org/10.1111/j.0954-6820.1982.tb01971.x] [PMID: 7113754]

Somer, M.; Kallio, J.; Pesonen, U.; Pyykkö, K.; Huupponen, R.; Scheinin, M. Influence of hydroxychloroquine on the bioavailability of oral metoprolol. Br. J. Clin. Pharmacol., 2000, 49(6), 549-554.
[http://dx.doi.org/10.1046/j.1365-2125.2000.00197.x] [PMID: 10848718]

Tsai, D.; Jamal, J.A.; Davis, J.S.; Lipman, J.; Roberts, J.A. Interethnic differences in pharmacokinetics of antibacterials. Clin. Pharmacokinet., 2015, 54(3), 243-260.
[http://dx.doi.org/10.1007/s40262-014-0209-3] [PMID: 25385446]

Zhou, N.; Pan, T.; Zhang, J.; Li, Q.; Zhang, X.; Bai, C.; Huang, F.; Peng, T.; Zhang, J.; Liu, C.; Tao, L.; Zhang, H. Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of ebola virus, middle east respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV). J. Biol. Chem., 2016, 291(17), 9218-9232.
[http://dx.doi.org/10.1074/jbc.M116.716100] [PMID: 26953343]

Pea, F. Plasma pharmacokinetics of antimicrobial agents in critically ill patients. Curr. Clin. Pharmacol., 2013, 8(1), 5-12.
[PMID: 22946868]

Byrne, C.J.; Parton, T.; McWhinney, B.; Fennell, J.P.; O’Byrne, P.; Deasy, E.; Egan, S.; Enright, H.; Desmond, R.; Ryder, S.A.; D’Arcy, D.M.; McHugh, J.; Roberts, J.A. Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy. J. Antimicrob. Chemother., 2018, 73(4), 995-1003.
[http://dx.doi.org/10.1093/jac/dkx473] [PMID: 29272419]

Liu, J.; Li, S.; Liu, J.; Liang, B.; Wang, X.; Wang, H.; Li, W.; Tong, Q.; Yi, J.; Zhao, L.; Xiong, L.; Guo, C.; Tian, J.; Luo, J.; Yao, J.; Pang, R.; Shen, H.; Peng, C.; Liu, T.; Zhang, Q.; Wu, J.; Xu, L.; Lu, S.; Wang, B.; Weng, Z.; Han, C.; Zhu, H.; Zhou, R.; Zhou, H.; Chen, X.; Ye, P.; Zhu, B.; Wang, L.; Zhou, W.; He, S.; He, Y.; Jie, S.; Wei, P.; Zhang, J.; Lu, Y.; Wang, W.; Zhang, L.; Li, L.; Zhou, F.; Wang, J.; Dittmer, U.; Lu, M.; Hu, Y.; Yang, D.; Zheng, X. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine, 2020, 55, 102763.
[http://dx.doi.org/10.1016/j.ebiom.2020.102763] [PMID: 32361250]

Ruan, Q.; Yang, K.; Wang, W.; Jiang, L.; Song, J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med., 2020, 46(5), 846-848.
[http://dx.doi.org/10.1007/s00134-020-05991-x] [PMID: 32125452]

Frey, N.; Grange, S.; Woodworth, T. Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritis. J. Clin. Pharmacol., 2010, 50(7), 754-766.
[http://dx.doi.org/10.1177/0091270009350623] [PMID: 20097931]

Abdallah, H.; Hsu, J.C.; Lu, P.; Fettner, S.; Zhang, X.; Douglass, W.; Bao, M.; Rowell, L.; Burmester, G.R.; Kivitz, A. Pharmacokinetic and pharmacodynamic analysis of subcutaneous tocilizumab in patients with rheumatoid arthritis from 2 randomized, controlled trials: SUMMACTA and BREVACTA. J. Clin. Pharmacol., 2017, 57(4), 459-468.
[http://dx.doi.org/10.1002/jcph.826] [PMID: 27599663]

Huet, T.; Beaussier, H.; Voisin, O.; Jouveshomme, S.; Dauriat, G.; Lazareth, I.; Sacco, E.; Naccache, J.M.; Bézie, Y.; Laplanche, S.; Le Berre, A.; Le Pavec, J.; Salmeron, S.; Emmerich, J.; Mourad, J.J.; Chatellier, G.; Hayem, G. Anakinra for severe forms of COVID-19: A cohort study. Lancet Rheumatol., 2020, 2(7), e393-e400.
[http://dx.doi.org/10.1016/S2665-9913(20)30164-8] [PMID: 32835245]

Yang, B.; Frazier, J.; McCabe, D.; Young, J. FRI0036 Population pharmacokinetics (pk) of anakinra in subjects with rheumatoid arthritis (ra). Speaker abstracts 2001, vol. 60. BMJ, 2001, A459, 3-A460.

Cohen, S.; Hurd, E.; Cush, J.; Schiff, M.; Weinblatt, M.E.; Moreland, L.W.; Kremer, J.; Bear, M.B.; Rich, W.J.; McCabe, D. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum., 2002, 46(3), 614-624.
[http://dx.doi.org/10.1002/art.10141] [PMID: 11920396]

Adcock, I.M.; Mumby, S. Glucocorticoids. Handb. Exp. Pharmacol., 2016, 237, 171-196.

Czock, D.; Keller, F.; Rasche, F.M.; Häussler, U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin. Pharmacokinet., 2005, 44(1), 61-98.
[http://dx.doi.org/10.2165/00003088-200544010-00003] [PMID: 15634032]

Dunn, T.E.; Ludwig, E.A.; Slaughter, R.L.; Camara, D.S.; Jusko, W.J. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Clin. Pharmacol. Ther., 1991, 49(5), 536-549.
[http://dx.doi.org/10.1038/clpt.1991.64] [PMID: 1827621]

Valsamakis, G.; Anwar, A.; Tomlinson, J.W.; Shackleton, C.H.L.; McTernan, P.G.; Chetty, R.; Wood, P.J.; Banerjee, A.K.; Holder, G.; Barnett, A.H.; Stewart, P.M.; Kumar, S. 11β-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab., 2004, 89(9), 4755-4761.
[http://dx.doi.org/10.1210/jc.2003-032240] [PMID: 15356090]

Derendorf, H.; Rohdewald, P.; Möllmann, H.; Rehder, J.; Barth, J.; Neveling, D. Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate. Biopharm. Drug Dispos., 1985, 6(4), 423-432.
[http://dx.doi.org/10.1002/bdd.2510060408] [PMID: 4084667]

Milsap, R.L.; Plaisance, K.I.; Jusko, W.J. Prednisolone disposition in obese men. Clin. Pharmacol. Ther., 1984, 36(6), 824-831.
[http://dx.doi.org/10.1038/clpt.1984.263] [PMID: 6499362]

Xu, J.; Nave, R.; Lahu, G.; Derom, E.; Derendorf, H. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. J. Clin. Pharmacol., 2010, 50(10), 1118-1127.
[http://dx.doi.org/10.1177/0091270009354994] [PMID: 20150524]

Mårs, U.; d’Argy, R.; Hallbeck, K.; Miller-Larsson, A.; Edsbäcker, S. Tissue accumulation kinetics of ciclesonide-active metabolite and budesonide in mice. Basic Clin. Pharmacol. Toxicol., 2013, 112(6), 401-411.
[http://dx.doi.org/10.1111/bcpt.12043] [PMID: 23256845]

Caly, L.; Druce, J.D.; Catton, M.G.; Jans, D.A.; Wagstaff, K.M. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res., 2020, 178, 104787.
[http://dx.doi.org/10.1016/j.antiviral.2020.104787] [PMID: 32251768]

Muñoz, J.; Ballester, M.R.; Antonijoan, R.M.; Gich, I.; Rodríguez, M.; Colli, E.; Gold, S.; Krolewiecki, A.J. Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers. PLoS Negl. Trop. Dis., 2018, 12(1), e0006020.
[http://dx.doi.org/10.1371/journal.pntd.0006020] [PMID: 29346388]

Bassissi, M.F.; Alvinerie, M.; Lespine, A. Macrocyclic lactones: Distribution in plasma lipoproteins of several animal species including humans. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2004, 138(4), 437-444.
[http://dx.doi.org/10.1016/j.cca.2004.07.011] [PMID: 15536051]

Ballent, M.; Lifschitz, A.; Virkel, G.; Sallovitz, J.; Lanusse, C. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: In vitro and in vivo assessments. Drug Metab. Dispos., 2006, 34(3), 457-463.
[http://dx.doi.org/10.1124/dmd.105.007757] [PMID: 16381664]

Tumminia, A.; Romano, R.; Brugaletta, G.; Scicali, R.; Biondi, G.; Oliveri, R.; Romano, M.; San Lio, P.M. The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study. Nutr. Metab. Cardiovasc. Dis., 2022, 32(7), 1635-1641.
[http://dx.doi.org/10.1016/j.numecd.2022.04.005] [PMID: 35508458]

So, M.; Takahashi, M.; Miyamoto, Y.; Ishisaka, Y.; Iwagami, M.; Tsugawa, Y.; Egorova, N.N.; Kuno, T. The effect of obesity on in-hospital mortality among patients with COVID-19 receiving corticosteroids. Diabetes Metab. Syndr., 2022, 16(1), 102373.
[http://dx.doi.org/10.1016/j.dsx.2021.102373] [PMID: 34979344]

Fioravanti, A.; Porcelli, B.; Terzuoli, L.; Bacarelli, M.R.; Tenti, S.; Cheleschi, S. Tocilizumab, adipokines and severe complications of COVID-19. Clin. Drug Investig., 2020, 40(9), 891-892.
[http://dx.doi.org/10.1007/s40261-020-00950-2] [PMID: 32661912]

Marconi, V.C.; Ramanan, A.V.; de Bono, S.; Kartman, C.E.; Krishnan, V.; Liao, R.; Piruzeli, M.L.B.; Goldman, J.D.; Alatorre-Alexander, J.; de Cassia Pellegrini, R.; Estrada, V.; Som, M.; Cardoso, A.; Chakladar, S.; Crowe, B.; Reis, P.; Zhang, X.; Adams, D.H.; Ely, E.W.; Ahn, M-Y.; Akasbi, M.; Alatorre-Alexander, J.; Altclas, J.D.; Ariel, F.; Ariza, H.A.; Atkar, C.; Bertetti, A.; Bhattacharya, M.; Briones, M.L.; Budhraja, A.; Burza, A.; Camacho Ortiz, A.; Caricchio, R.; Casas, M.; Cevoli Recio, V.; Choi, W.S.; Cohen, E.; Comulada-Rivera, A.; Cook, P.; Cornejo Juarez, D.P.; Daniel, C.; Degrecci Relvas, L.F.; Dominguez Cherit, J.G.; Ellerin, T.; Enikeev, D.; Erico Tanni Minamoto, S.; Estrada, V.; Fiss, E.; Furuichi, M.; Giovanni Luz, K.; Goldman, J.D.; Gonzalez, O.; Gordeev, I.; Gruenewald, T.; Hamamoto Sato, V.A.; Heo, E.Y.; Heo, J.Y.; Hermida, M.; Hirai, Y.; Hutchinson, D.; Iastrebner, C.; Ioachimescu, O.; Jain, M.; Juliani Souza Lima, M.P.; Khan, A.; Kremer, A.E.; Lawrie, T.; MacElwee, M.; Madhani-Lovely, F.; Malhotra, V.; Martínez Resendez, M.F.; McKinnell, J.; Milligan, P.; Minelli, C.; Moran Rodriguez, M.A.; Parody, M.L.; Paulin, P.; Pellegrini, R.C.; Pemu, P.; Procopio Carvalho, A.C.; Puoti, M.; Purow, J.; Ramesh, M.; Rea Neto, A.; Rea Neto, A.; Robinson, P.; Rodrigues, C.; Rojas Velasco, G.; Saraiva, J.F.K.; Scheinberg, M.; Schreiber, S.; Scublinsky, D.; Sevciovic Grumach, A.; Shawa, I.; Simon Campos, J.; Sofat, N.; Som, M.; Spinner, C.D.; Sprinz, E.; Stienecker, R.; Suarez, J.; Tachikawa, N.; Tahir, H.; Tiffany, B.; Vishnevsky, A.; Westheimer Cavalcante, A.; Zirpe, K. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): A randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir. Med., 2021, 9(12), 1407-1418.
[http://dx.doi.org/10.1016/S2213-2600(21)00331-3] [PMID: 34480861]

Barletta, J.F.; Erstad, B.L. Drug dosing in hospitalized obese patients with COVID-19. Crit. Care, 2022, 26(1), 60.
[http://dx.doi.org/10.1186/s13054-022-03941-1] [PMID: 35287690]

Hanley, M.J.; Abernethy, D.R.; Greenblatt, D.J. Effect of obesity on the pharmacokinetics of drugs in humans. Clin. Pharmacokinet., 2010, 49(2), 71-87.
[http://dx.doi.org/10.2165/11318100-000000000-00000] [PMID: 20067334]

Berezhkovskiy, L.M. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects. J. Pharm. Sci., 2011, 100(6), 2482-2497.
[http://dx.doi.org/10.1002/jps.22444] [PMID: 21254063]

Benedek, I.H. Fiske d, W.D.; Griffen, W.O.; Bell, R.M.; Blouin, R.A.; McNamara, P.J. Serum alpha 1-acid glycoprotein and the binding of drugs in obesity. Br. J. Clin. Pharmacol., 1983, 16(6), 751-754.
[http://dx.doi.org/10.1111/j.1365-2125.1983.tb02258.x] [PMID: 6661365]

Blouin, R.A.; Warren, G.W. Pharmacokinetic considerations in obesity. J. Pharm. Sci., 1999, 88(1), 1-7.
[http://dx.doi.org/10.1021/js980173a] [PMID: 9874695]

Núñez-Ruiz, A.; Sánchez-Brena, F.; López-Pacheco, C.; Acevedo-Domínguez, N.A.; Soldevila, G. Obesity modulates the immune macroenvironment associated with breast cancer development. PLoS One, 2022, 17(4), e0266827.
[http://dx.doi.org/10.1371/journal.pone.0266827] [PMID: 35472214]

Xiao, J.; Shen, K.; Liu, K.; Wang, Y.; Fan, H.; Cheng, Q.; Zhou, X.; Hu, L.; Wang, G.; Xu, Z.; Yang, L. Obesity promotes lipid accumulation in lymph node metastasis of gastric cancer: A retrospective case-control study. Lipids Health Dis., 2022, 21, 123.

Heymsfield, S.B.; Wadden, T.A.; Kalangi, S.K. Mechanisms, pathophysiology, and management of obesity. N. Engl. J. Med., 2017, 376, 254-266.

Alti, D.; Sambamurthy, C.; Kalangi, S.K. Emergence of leptin in infection and immunity: Scope and challenges in vaccines formulation. Front. Cell. Infect. Microbiol., 2018, 8, 147.
[http://dx.doi.org/10.3389/fcimb.2018.00147] [PMID: 29868503]

Popkin, B.M.; Du, S.; Green, W.D.; Beck, M.A.; Algaith, T.; Herbst, C.H.; Alsukait, R.F.; Alluhidan, M.; Alazemi, N.; Shekar, M. Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships. Obes. Rev., 2020, 21(11), e13128.
[http://dx.doi.org/10.1111/obr.13128] [PMID: 32845580]

Kane, H.; Lynch, L. Innate immune control of adipose tissue homeostasis. Trends Immunol., 2019, 40(9), 857-872.
[http://dx.doi.org/10.1016/j.it.2019.07.006] [PMID: 31399336]

Khanna, D.; Khanna, S.; Khanna, P.; Kahar, P.; Patel, B.M. Obesity: A chronic low-grade inflammation and its markers. Cureus, 2022, 14(2), e22711.
[http://dx.doi.org/10.7759/cureus.22711] [PMID: 35386146]

Chait, A.; den Hartigh, L.J. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front. Cardiovasc. Med., 2020, 7, 22.
[http://dx.doi.org/10.3389/fcvm.2020.00022] [PMID: 32158768]

Karlsson, E.A.; Sheridan, P.A.; Beck, M.A. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J. Immunol., 2010, 184(6), 3127-3133.
[http://dx.doi.org/10.4049/jimmunol.0903220] [PMID: 20173021]

Karlsson, E.A.; Beck, M.A. The burden of obesity on infectious disease. Exp. Biol. Med., 2010, 235(12), 1412-1424.
[http://dx.doi.org/10.1258/ebm.2010.010227] [PMID: 21127339]

Aziz, R.; Sherwani, A.Y.; Al Mahri, S.; Malik, S.S.; Mohammad, S. Why are obese people predisposed to severe disease in viral respiratory infections? Obesities, 2023, 3(1), 46-58.
[http://dx.doi.org/10.3390/obesities3010005]

Callaway, E. The race for coronavirus vaccines: A graphical guide. Nature, 2020, 580(7805), 576-577.
[http://dx.doi.org/10.1038/d41586-020-01221-y] [PMID: 32346146]

Forni, G.; Mantovani, A. COVID-19 vaccines: Where we stand and challenges ahead. Cell Death Differ., 2021, 28(2), 626-639.
[http://dx.doi.org/10.1038/s41418-020-00720-9] [PMID: 33479399]

Machado, B.A.S.; Hodel, K.V.S.; Fonseca, L.M.S.; Mascarenhas, L.A.B.; Andrade, L.P.C.S.; Rocha, V.P.C.; Soares, M.B.P.; Berglund, P.; Duthie, M.S.; Reed, S.G.; Badaró, R. The importance of RNA-based vaccines in the fight against COVID-19: An overview. Vaccines, 2021, 9(11), 1345.
[http://dx.doi.org/10.3390/vaccines9111345] [PMID: 34835276]

Ledford, H. Moderna COVID vaccine becomes second to get US authorization. Nature, 2020.
[http://dx.doi.org/10.1038/d41586-020-03593-7] [PMID: 33340017]

Polack, F.P.; Thomas, S.J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; Pérez Marc, G.; Moreira, E.D.; Zerbini, C.; Bailey, R.; Swanson, K.A.; Roychoudhury, S.; Koury, K.; Li, P.; Kalina, W.V.; Cooper, D.; Frenck, R.W., Jr; Hammitt, L.L.; Türeci, Ö.; Nell, H.; Schaefer, A.; Ünal, S.; Tresnan, D.B.; Mather, S.; Dormitzer, P.R.; Şahin, U.; Jansen, K.U.; Gruber, W.C. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med., 2020, 383(27), 2603-2615.
[http://dx.doi.org/10.1056/NEJMoa2034577] [PMID: 33301246]

Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, C.B.; McGettigan, J.; Khetan, S.; Segall, N.; Solis, J.; Brosz, A.; Fierro, C.; Schwartz, H.; Neuzil, K.; Corey, L.; Gilbert, P.; Janes, H.; Follmann, D.; Marovich, M.; Mascola, J.; Polakowski, L.; Ledgerwood, J.; Graham, B.S.; Bennett, H.; Pajon, R.; Knightly, C.; Leav, B.; Deng, W.; Zhou, H.; Han, S.; Ivarsson, M.; Miller, J.; Zaks, T. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med., 2021, 384(5), 403-416.
[http://dx.doi.org/10.1056/NEJMoa2035389] [PMID: 33378609]

Sadoff, J.; Gray, G.; Vandebosch, A.; Cárdenas, V.; Shukarev, G.; Grinsztejn, B.; Goepfert, P.A.; Truyers, C.; Fennema, H.; Spiessens, B.; Offergeld, K.; Scheper, G.; Taylor, K.L.; Robb, M.L.; Treanor, J.; Barouch, D.H.; Stoddard, J.; Ryser, M.F.; Marovich, M.A.; Neuzil, K.M.; Corey, L.; Cauwenberghs, N.; Tanner, T.; Hardt, K.; Ruiz-Guiñazú, J.; Le Gars, M.; Schuitemaker, H.; Van Hoof, J.; Struyf, F.; Douoguih, M. Safety and efficacy of single-dose Ad26.COV2.S Vaccine against Covid-19. N. Engl. J. Med., 2021, 384(23), 2187-2201.
[http://dx.doi.org/10.1056/NEJMoa2101544] [PMID: 33882225]

Falsey, A.R.; Sobieszczyk, M.E.; Hirsch, I.; Sproule, S.; Robb, M.L.; Corey, L.; Neuzil, K.M.; Hahn, W.; Hunt, J.; Mulligan, M.J.; McEvoy, C.; DeJesus, E.; Hassman, M.; Little, S.J.; Pahud, B.A.; Durbin, A.; Pickrell, P.; Daar, E.S.; Bush, L.; Solis, J.; Carr, Q.O.; Oyedele, T.; Buchbinder, S.; Cowden, J.; Vargas, S.L.; Guerreros Benavides, A.; Call, R.; Keefer, M.C.; Kirkpatrick, B.D.; Pullman, J.; Tong, T.; Brewinski Isaacs, M.; Benkeser, D.; Janes, H.E.; Nason, M.C.; Green, J.A.; Kelly, E.J.; Maaske, J.; Mueller, N.; Shoemaker, K.; Takas, T.; Marshall, R.P.; Pangalos, M.N.; Villafana, T.; Gonzalez-Lopez, A. Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. N. Engl. J. Med., 2021, 385(25), 2348-2360.
[http://dx.doi.org/10.1056/NEJMoa2105290] [PMID: 34587382]

Falagas, M.E.; Athanasoulia, A.P.; Peppas, G.; Karageorgopoulos, D.E. Effect of body mass index on the outcome of infections: A systematic review. Obes. Rev., 2009, 10(3), 280-289.
[http://dx.doi.org/10.1111/j.1467-789X.2008.00546.x] [PMID: 19243518]

Eliakim, A.; Swindt, C.; Zaldivar, F.; Casali, P.; Cooper, D.M. Reduced tetanus antibody titers in overweight children. Autoimmunity, 2006, 39(2), 137-141.
[http://dx.doi.org/10.1080/08916930600597326] [PMID: 16698670]

Ealey, K.N.; Phillips, J.; Sung, H.K. COVID-19 and obesity: Fighting two pandemics with intermittent fasting. Trends Endocrinol. Metab., 2021, 32(9), 706-720.
[http://dx.doi.org/10.1016/j.tem.2021.06.004] [PMID: 34275726]

Frasca, D.; Reidy, L.; Cray, C.; Diaz, A.; Romero, M.; Kahl, K.; Blomberg, B.B. Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients. PLoS One, 2021, 16(3), e0245424.
[http://dx.doi.org/10.1371/journal.pone.0245424] [PMID: 33760825]

Pellini, R.; Venuti, A.; Pimpinelli, F.; Abril, E.; Blandino, G.; Campo, F.; Conti, L.; De Virgilio, A.; De Marco, F.; Gino, E.; Domenico, D.; Di Bella, O. Obesity may hamper SARS-CoV-2 vaccine immunogenicity. MedRxiv, 2021, 2021.

Ou, X.; Jiang, J.; Lin, B.; Liu, Q.; Lin, W.; Chen, G.; Wen, J. Antibody responses to COVID‐19 vaccination in people with obesity: A systematic review and meta‐analysis. Influenza Other Respir. Viruses, 2023, 17(1), e13078.
[http://dx.doi.org/10.1111/irv.13078] [PMID: 36535669]

Szczerbiński, Ł.; Okruszko, M.A.; Szabłowski, M.; Warpechowski, J.; Paszko, A.; Citko, A.; Konopka, P.; Bauer, W.; Krętowski, A.J. Immune response to vaccination against covid-19 at different second-dose intervals and their associations with metabolic parameters. Vaccines, 2023, 11(1), 149.
[http://dx.doi.org/10.3390/vaccines11010149] [PMID: 36679994]

Watanabe, M.; Balena, A.; Tuccinardi, D.; Tozzi, R.; Risi, R.; Masi, D.; Caputi, A.; Rossetti, R.; Spoltore, M.E.; Filippi, V.; Gangitano, E.; Manfrini, S.; Mariani, S.; Lubrano, C.; Lenzi, A.; Mastroianni, C.; Gnessi, L. Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccine. Diabetes Metab. Res. Rev., 2022, 38(1), e3465.
[http://dx.doi.org/10.1002/dmrr.3465] [PMID: 33955644]

Uysal, E.B.; Gümüş, S.; Bektöre, B.; Bozkurt, H.; Gözalan, A. Evaluation of antibody response after COVID‐19 vaccination of healthcare workers. J. Med. Virol., 2022, 94(3), 1060-1066.
[http://dx.doi.org/10.1002/jmv.27420] [PMID: 34704620]

Lee, S.W.; Moon, J.Y.; Lee, S.K.; Lee, H.; Moon, S.; Chung, S.J.; Yeo, Y.; Park, T.S.; Park, D.W.; Kim, T.H.; Sohn, J.W.; Yoon, H.J.; Kim, S.H. Anti-SARS-CoV-2 spike protein RBD antibody levels after receiving a second dose of ChAdOx1 nCov-19 (AZD1222) vaccine in healthcare workers: lack of association with age, sex, obesity, and adverse reactions. Front. Immunol., 2021, 12, 779212.
[http://dx.doi.org/10.3389/fimmu.2021.779212] [PMID: 34899739]

Rudolph, A.; Mitchell, J.; Barrett, J.; Sköld, H.; Taavola, H.; Erlanson, N.; Melgarejo-González, C.; Yue, Q.Y. Global safety monitoring of COVID-19 vaccines: How pharmacovigilance rose to the challenge. Ther. Adv. Drug Saf., 2022, 13.
[http://dx.doi.org/10.1177/20420986221118972] [PMID: 36052399]

Oosterhuis, I.; Scholl, J.; van Puijenbroek, E.; Kant, A.; van Hunsel, F. Optimizing safety surveillance for covid-19 vaccines at the national pharmacovigilance centre lareb: One Year of COVID-19 vaccine experience. Drug Saf., 2023, 46(1), 65-75.
[http://dx.doi.org/10.1007/s40264-022-01253-5] [PMID: 36350465]

Crommelynck, S.; Thill, P. Pharmacovigilance for COVID-19 vaccines: A 1-year experience in France. Infect. Dis. Now, 2022, 52(8), S16-S18.
[http://dx.doi.org/10.1016/j.idnow.2022.09.018] [PMID: 36152793]

Amancio-Chassin, O. Pharmacovigilance in the vaccination program against coronavirus disease 19. Revista Medica del Hospital General de M xico, 2021, 84(3), 92-95.
[http://dx.doi.org/10.24875/HGMX.M21000041]

Naniche, D.; Hotez, P.; Bottazzi, M.E.; Ergonul, O.; Figueroa, J.P.; Gilbert, S.; Gursel, M.; Hassanain, M.; Kang, G.; Kaslow, D.; Kim, J.H.; Lall, B.; Larson, H.; Sheahan, T.; Shoham, S.; Wilder-Smith, A.; Sow, S.O.; Strub-Wourgaft, N.; Yadav, P.; Batista, C. Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment. EClinicalMedicine, 2021, 36, 100925.
[http://dx.doi.org/10.1016/j.eclinm.2021.100925] [PMID: 34099998]

Bhandari, B.; Rayamajhi, G.; Lamichhane, P.; Shenoy, A.K. Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review. BioMed Res. Int., 2022, 2022, 1-11.
[http://dx.doi.org/10.1155/2022/2911333] [PMID: 36017393]

Kadali, R.A.K.; Janagama, R.; Peruru, S.; Gajula, V.; Madathala, R.R.; Chennaiahgari, N.; Malayala, S.V. Non‐life‐threatening adverse effects with COVID‐19 mRNA‐1273 vaccine: A randomized, cross‐sectional study on healthcare workers with detailed self‐reported symptoms. J. Med. Virol., 2021, 93(7), 4420-4429.
[http://dx.doi.org/10.1002/jmv.26996] [PMID: 33822361]

Menni, C.; Klaser, K.; May, A.; Polidori, L.; Capdevila, J.; Louca, P.; Sudre, C.H.; Nguyen, L.H.; Drew, D.A.; Merino, J.; Hu, C.; Selvachandran, S.; Antonelli, M.; Murray, B.; Canas, L.S.; Molteni, E.; Graham, M.S.; Modat, M.; Joshi, A.D.; Mangino, M.; Hammers, A.; Goodman, A.L.; Chan, A.T.; Wolf, J.; Steves, C.J.; Valdes, A.M.; Ourselin, S.; Spector, T.D. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study. Lancet Infect. Dis., 2021, 21(7), 939-949.
[http://dx.doi.org/10.1016/S1473-3099(21)00224-3] [PMID: 33930320]

Doroftei, B.; Ciobica, A.; Ilie, O.D.; Maftei, R.; Ilea, C. Mini-review discussing the reliability and efficiency of COVID-19 vaccines. Diagnostics, 2021, 11(4), 579.
[http://dx.doi.org/10.3390/diagnostics11040579] [PMID: 33804914]

Ledford, H. COVID vaccines and blood clots: What researchers know so far. Nature, 2021, 596, 479-481.
[http://dx.doi.org/10.1038/d41586-021-02291-2]

Aryal, S.; Shrestha, A. Adverse events following immunization with Sinopharm (Vero Cell), inactivated COVID-19 vaccine. J. Patan Acad. Heal. Sci., 2021, 8, 18-24.
[http://dx.doi.org/10.3126/jpahs.v8i2.31099]

Riad, A.; Sağıroğlu, D.; Üstün, B.; Pokorná, A.; Klugarová, J.; Attia, S.; Klugar, M. Article prevalence and risk factors of coronavac side effects: An independent cross-sectional study among healthcare workers in turkey. J. Clin. Med., 2021, 10(12), 2629.
[http://dx.doi.org/10.3390/jcm10122629] [PMID: 34203769]

Woo, E.J.; Mba-Jonas, A.; Thomas, A.; Baer, B.; Day, B.; Kim, Y.; Gomez-Lorenzo, M.; Nair, N. Thromboembolic events after Ad.26. COV2. S COVID ‐19 vaccine: Reports to the Vaccine Adverse Event Reporting System. Pharmacoepidemiol. Drug Saf., 2022, 31(11), 1174-1181.
[http://dx.doi.org/10.1002/pds.5523] [PMID: 36065046]

Wang, G.L.; Wang, Z.Y.; Duan, L.J.; Meng, Q.C.; Jiang, M.D.; Cao, J.; Yao, L.; Zhu, K.L.; Cao, W.C.; Ma, M.J. Susceptibility of circulating SARS-CoV-2 variants to neutralization. N. Engl. J. Med., 2021, 384(24), 2354-2356.
[http://dx.doi.org/10.1056/NEJMc2103022] [PMID: 33822491]

Harvey, W.T.; Carabelli, A.M.; Jackson, B.; Gupta, R.K.; Thomson, E.C.; Harrison, E.M.; Ludden, C.; Reeve, R.; Rambaut, A.; Peacock, S.J.; Robertson, D.L. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol., 2021, 19(7), 409-424.
[http://dx.doi.org/10.1038/s41579-021-00573-0] [PMID: 34075212]

Engelbrecht, F.A.; Scholes, R.J. Test for Covid-19 seasonality and the risk of second waves. One Health, 2021, 12, 100202.
[http://dx.doi.org/10.1016/j.onehlt.2020.100202] [PMID: 33283035]

Callaway, E. Beyond Omicron: What’s next for COVID’s viral evolution. Nature, 2021, 600(7888), 204-207.
[http://dx.doi.org/10.1038/d41586-021-03619-8] [PMID: 34876665]

Dicker, D.; Golan, R.; Baker, J.L.; Busetto, L.; Frühbeck, G.; Goossens, G.H.; Halford, J.C.G.; Holm, J.C.; Woodward, E.; Farpour-Lambert, N.J. Vaccinating people with obesity for COVID-19: EASO call for action. Obes. Facts, 2021, 14(3), 334-335.
[http://dx.doi.org/10.1159/000516524] [PMID: 33915546]

Raveendran, A.V.; Jayadevan, R.; Sashidharan, S. Long COVID: An overview. Diabetes Metab. Syndr., 2021, 15(3), 869-875.
[http://dx.doi.org/10.1016/j.dsx.2021.04.007] [PMID: 33892403]

Membrilla, J.A.; Caronna, E.; Trigo-López, J.; González-Martínez, A.; Layos-Romero, A.; Pozo-Rosich, P.; Guerrero-Peral, Á.; Gago-Veiga, A.B.; Andrés-López, A.; Díaz de Terán, J. Persistent headache after COVID-19: Pathophysioloy, clinic and treatment. Neurol. Perspect., 2021, 1, S31-S36.
[http://dx.doi.org/10.1016/j.neurop.2021.10.003]

Yelin, D.; Margalit, I.; Nehme, M.; Bordas-Martínez, J.; Pistelli, F.; Yahav, D.; Guessous, I.; Durà-Miralles, X.; Carrozzi, L.; Shapira-Lichter, I.; Vetter, P.; Peleato-Catalan, D.; Tiseo, G.; Wirtheim, E.; Kaiser, L.; Gudiol, C.; Falcone, M.; Leibovici, L. Patterns of long COVID symptoms: A multi-center cross sectional study. J. Clin. Med., 2022, 11(4), 898.
[http://dx.doi.org/10.3390/jcm11040898] [PMID: 35207171]

Iqbal, F.M.; Lam, K.; Sounderajah, V.; Clarke, J.M.; Ashrafian, H.; Darzi, A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine, 2021, 36, 100899.
[http://dx.doi.org/10.1016/j.eclinm.2021.100899] [PMID: 34036253]

Azzolini, E.; Levi, R.; Sarti, R.; Pozzi, C.; Mollura, M.; Mantovani, A.; Rescigno, M. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA, 2022, 328(7), 676-678.
[http://dx.doi.org/10.1001/jama.2022.11691] [PMID: 35796131]

Crook, H.; Raza, S.; Nowell, J.; Young, M.; Edison, P. Long covid—mechanisms, risk factors, and management. BMJ, 2021, 374(1648), n1648.
[http://dx.doi.org/10.1136/bmj.n1648] [PMID: 34312178]

Nalbandian, A.; Sehgal, K.; Gupta, A.; Madhavan, M.V.; McGroder, C.; Stevens, J.S.; Cook, J.R.; Nordvig, A.S.; Shalev, D.; Sehrawat, T.S.; Ahluwalia, N.; Bikdeli, B.; Dietz, D.; Der-Nigoghossian, C.; Liyanage-Don, N.; Rosner, G.F.; Bernstein, E.J.; Mohan, S.; Beckley, A.A.; Seres, D.S.; Choueiri, T.K.; Uriel, N.; Ausiello, J.C.; Accili, D.; Freedberg, D.E.; Baldwin, M.; Schwartz, A.; Brodie, D.; Garcia, C.K.; Elkind, M.S.V.; Connors, J.M.; Bilezikian, J.P.; Landry, D.W.; Wan, E.Y. Post-acute COVID-19 syndrome. Nat. Med., 2021, 27(4), 601-615.
[http://dx.doi.org/10.1038/s41591-021-01283-z] [PMID: 33753937]

Vimercati, L.; De Maria, L.; Quarato, M.; Caputi, A.; Gesualdo, L.; Migliore, G.; Cavone, D.; Sponselli, S.; Pipoli, A.; Inchingolo, F.; Scarano, A.; Lorusso, F.; Stefanizzi, P.; Tafuri, S. Association between Long COVID and Overweight/Obesity. J. Clin. Med., 2021, 10(18), 4143.
[http://dx.doi.org/10.3390/jcm10184143] [PMID: 34575251]

Heubner, L.; Petrick, P.L.; Güldner, A.; Bartels, L.; Ragaller, M.; Mirus, M.; Rand, A.; Tiebel, O.; Beyer-Westendorf, J.; Rößler, M.; Schmitt, J.; Koch, T.; Spieth, P.M. Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome. Sci. Rep., 2022, 12(1), 18418.
[http://dx.doi.org/10.1038/s41598-022-22107-1] [PMID: 36319681]

Xiang, M.; Wu, X.; Jing, H.; Novakovic, V.A.; Shi, J. The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury. Front. Cardiovasc. Med., 2023, 10, 1062491.
[http://dx.doi.org/10.3389/fcvm.2023.1062491] [PMID: 36824451]

Mattioli, A.V.; Coppi, F.; Nasi, M.; Pinti, M.; Gallina, S. Long COVID: A new challenge for prevention of obesity in women. Am. J. Lifestyle Med., 2023, 17(1), 164-168.
[http://dx.doi.org/10.1177/15598276221111054] [PMID: 36636391]

Evans, R.A.; Leavy, O.C.; Richardson, M.; Elneima, O.; McAuley, H.J.C.; Shikotra, A.; Singapuri, A.; Sereno, M.; Saunders, R.M.; Harris, V.C.; Houchen-Wolloff, L.; Aul, R.; Beirne, P.; Bolton, C.E.; Brown, J.S.; Choudhury, G.; Diar-Bakerly, N.; Easom, N.; Echevarria, C.; Fuld, J.; Hart, N.; Hurst, J.; Jones, M.G.; Parekh, D.; Pfeffer, P.; Rahman, N.M.; Rowland-Jones, S.L.; Shah, A.M.; Wootton, D.G.; Chalder, T.; Davies, M.J.; De Soyza, A.; Geddes, J.R.; Greenhalf, W.; Greening, N.J.; Heaney, L.G.; Heller, S.; Howard, L.S.; Jacob, J.; Jenkins, R.G.; Lord, J.M.; Man, W.D-C.; McCann, G.P.; Neubauer, S.; Openshaw, P.J.M.; Porter, J.C.; Rowland, M.J.; Scott, J.T.; Semple, M.G.; Singh, S.J.; Thomas, D.C.; Toshner, M.; Lewis, K.E.; Thwaites, R.S.; Briggs, A.; Docherty, A.B.; Kerr, S.; Lone, N.I.; Quint, J.; Sheikh, A.; Thorpe, M.; Zheng, B.; Chalmers, J.D.; Ho, L.P.; Horsley, A.; Marks, M.; Poinasamy, K.; Raman, B.; Harrison, E.M.; Wain, L.V.; Brightling, C.E.; Abel, K.; Adamali, H.; Adeloye, D.; Adeyemi, O.; Adrego, R.; Aguilar Jimenez, L.A.; Ahmad, S.; Ahmad Haider, N.; Ahmed, R.; Ahwireng, N.; Ainsworth, M.; Al-Sheklly, B.; Alamoudi, A.; Ali, M.; Aljaroof, M.; All, A.M.; Allan, L.; Allen, R.J.; Allerton, L.; Allsop, L.; Almeida, P.; Altmann, D.; Alvarez Corral, M.; Amoils, S.; Anderson, D.; Antoniades, C.; Arbane, G.; Arias, A.; Armour, C.; Armstrong, L.; Armstrong, N.; Arnold, D.; Arnold, H.; Ashish, A.; Ashworth, A.; Ashworth, M.; Aslani, S.; Assefa-Kebede, H.; Atkin, C.; Atkin, P.; Aung, H.; Austin, L.; Avram, C.; Ayoub, A.; Babores, M.; Baggott, R.; Bagshaw, J.; Baguley, D.; Bailey, L.; Baillie, J.K.; Bain, S.; Bakali, M.; Bakau, M.; Baldry, E.; Baldwin, D.; Ballard, C.; Banerjee, A.; Bang, B.; Barker, R.E.; Barman, L.; Barratt, S.; Barrett, F.; Basire, D.; Basu, N.; Bates, M.; Bates, A.; Batterham, R.; Baxendale, H.; Bayes, H.; Beadsworth, M.; Beckett, P.; Beggs, M.; Begum, M.; Bell, D.; Bell, R.; Bennett, K.; Beranova, E.; Bermperi, A.; Berridge, A.; Berry, C.; Betts, S.; Bevan, E.; Bhui, K.; Bingham, M.; Birchall, K.; Bishop, L.; Bisnauthsing, K.; Blaikely, J.; Bloss, A.; Bolger, A.; Bonnington, J.; Botkai, A.; Bourne, C.; Bourne, M.; Bramham, K.; Brear, L.; Breen, G.; Breeze, J.; Bright, E.; Brill, S.; Brindle, K.; Broad, L.; Broadley, A.; Brookes, C.; Broome, M.; Brown, A.; Brown, A.; Brown, J.; Brown, J.; Brown, M.; Brown, M.; Brown, V.; Brugha, T.; Brunskill, N.; Buch, M.; Buckley, P.; Bularga, A.; Bullmore, E.; Burden, L.; Burdett, T.; Burn, D.; Burns, G.; Burns, A.; Busby, J.; Butcher, R.; Butt, A.; Byrne, S.; Cairns, P.; Calder, P.C.; Calvelo, E.; Carborn, H.; Card, B.; Carr, C.; Carr, L.; Carson, G.; Carter, P.; Casey, A.; Cassar, M.; Cavanagh, J.; Chablani, M.; Chambers, R.C.; Chan, F.; Channon, K.M.; Chapman, K.; Charalambou, A.; Chaudhuri, N.; Checkley, A.; Chen, J.; Cheng, Y.; Chetham, L.; Childs, C.; Chilvers, E.R.; Chinoy, H.; Chiribiri, A.; Chong-James, K.; Choudhury, N.; Chowienczyk, P.; Christie, C.; Chrystal, M.; Clark, D.; Clark, C.; Clarke, J.; Clohisey, S.; Coakley, G.; Coburn, Z.; Coetzee, S.; Cole, J.; Coleman, C.; Conneh, F.; Connell, D.; Connolly, B.; Connor, L.; Cook, A.; Cooper, B.; Cooper, J.; Cooper, S.; Copeland, D.; Cosier, T.; Coulding, M.; Coupland, C.; Cox, E.; Craig, T.; Crisp, P.; Cristiano, D.; Crooks, M.G.; Cross, A.; Cruz, I.; Cullinan, P.; Cuthbertson, D.; Daines, L.; Dalton, M.; Daly, P.; Daniels, A.; Dark, P.; Dasgin, J.; David, A.; David, C.; Davies, E.; Davies, F.; Davies, G.; Davies, G.A.; Davies, K.; Dawson, J.; Daynes, E.; Deakin, B.; Deans, A.; Deas, C.; Deery, J.; Defres, S.; Dell, A.; Dempsey, K.; Denneny, E.; Dennis, J.; Dewar, A.; Dharmagunawardena, R.; Dickens, C.; Dipper, A.; Diver, S.; Diwanji, S.N.; Dixon, M.; Djukanovic, R.; Dobson, H.; Dobson, S.L.; Donaldson, A.; Dong, T.; Dormand, N.; Dougherty, A.; Dowling, R.; Drain, S.; Draxlbauer, K.; Drury, K.; Dulawan, P.; Dunleavy, A.; Dunn, S.; Earley, J.; Edwards, S.; Edwardson, C.; El-Taweel, H.; Elliott, A.; Elliott, K.; Ellis, Y.; Elmer, A.; Evans, D.; Evans, H.; Evans, J.; Evans, R.; Evans, R.I.; Evans, T.; Evenden, C.; Evison, L.; Fabbri, L.; Fairbairn, S.; Fairman, A.; Fallon, K.; Faluyi, D.; Favager, C.; Fayzan, T.; Featherstone, J.; Felton, T.; Finch, J.; Finney, S.; Finnigan, J.; Finnigan, L.; Fisher, H.; Fletcher, S.; Flockton, R.; Flynn, M.; Foot, H.; Foote, D.; Ford, A.; Forton, D.; Fraile, E.; Francis, C.; Francis, R.; Francis, S.; Frankel, A.; Fraser, E.; Free, R.; French, N.; Fu, X.; Furniss, J.; Garner, L.; Gautam, N.; George, J.; George, P.; Gibbons, M.; Gill, M.; Gilmour, L.; Gleeson, F.; Glossop, J.; Glover, S.; Goodman, N.; Goodwin, C.; Gooptu, B.; Gordon, H.; Gorsuch, T.; Greatorex, M.; Greenhaff, P.L.; Greenhalgh, A.; Greenwood, J.; Gregory, H.; Gregory, R.; Grieve, D.; Griffin, D.; Griffiths, L.; Guerdette, A-M.; Guillen Guio, B.; Gummadi, M.; Gupta, A.; Gurram, S.; Guthrie, E.; Guy, Z.; H Henson, H; Hadley, K.; Haggar, A.; Hainey, K.; Hairsine, B.; Haldar, P.; Hall, I.; Hall, L.; Halling-Brown, M.; Hamil, R.; Hancock, A.; Hancock, K.; Hanley, N.A.; Haq, S.; Hardwick, H.E.; Hardy, E.; Hardy, T.; Hargadon, B.; Harrington, K.; Harris, E.; Harrison, P.; Harvey, A.; Harvey, M.; Harvie, M.; Haslam, L.; Havinden-Williams, M.; Hawkes, J.; Hawkings, N.; Haworth, J.; Hayday, A.; Haynes, M.; Hazeldine, J.; Hazelton, T.; Heeley, C.; Heeney, J.L.; Heightman, M.; Henderson, M.; Hesselden, L.; Hewitt, M.; Highett, V.; Hillman, T.; Hiwot, T.; Hoare, A.; Hoare, M.; Hockridge, J.; Hogarth, P.; Holbourn, A.; Holden, S.; Holdsworth, L.; Holgate, D.; Holland, M.; Holloway, L.; Holmes, K.; Holmes, M.; Holroyd Hind, B.; Holt, L.; Hormis, A.; Hosseini, A.; Hotopf, M.; Howard, K.; Howell, A.; Hufton, E.; Hughes, A.D.; Hughes, J.; Hughes, R.; Humphries, A.; Huneke, N.; Hurditch, E.; Husain, M.; Hussell, T.; Hutchinson, J.; Ibrahim, W.; Ilyas, F.; Ingham, J.; Ingram, L.; Ionita, D.; Isaacs, K.; Ismail, K.; Jackson, T.; James, W.Y.; Jarman, C.; Jarrold, I.; Jarvis, H.; Jastrub, R.; Jayaraman, B.; Jezzard, P.; Jiwa, K.; Johnson, C.; Johnson, S.; Johnston, D.; Jolley, C.J.; Jones, D.; Jones, G.; Jones, H.; Jones, H.; Jones, I.; Jones, L.; Jones, S.; Jose, S.; Kabir, T.; Kaltsakas, G.; Kamwa, V.; Kanellakis, N.; Kaprowska,; Kausar, Z.; Keenan, N.; Kelly, S.; Kemp, G.; Kerslake, H.; Key, A.L.; Khan, F.; Khunti, K.; Kilroy, S.; King, B.; King, C.; Kingham, L.; Kirk, J.; Kitterick, P.; Klenerman, P.; Knibbs, L.; Knight, S.; Knighton, A.; Kon, O.; Kon, S.; Kon, S.S.; Koprowska, S.; Korszun, A.; Koychev, I.; Kurasz, C.; Kurupati, P.; Laing, C.; Lamlum, H.; Landers, G.; Langenberg, C.; Lasserson, D.; Lavelle Langham, L.; Lawrie, A.; Lawson, C.; Lawson, C.; Layton, A.; Lea, A.; Lee, D.; Lee, J-H.; Lee, E.; Leitch, K.; Lenagh, R.; Lewis, D.; Lewis, J.; Lewis, V.; Lewis-Burke, N.; Li, X.; Light, T.; Lightstone, L.; Lilaonitkul, W.; Lim, L.; Linford, S.; Lingford Hughes, A.; Lipman, M.; Liyanage, K.; Lloyd, A.; Logan, S.; Lomas, D.; Loosley, R.; Lota, H.; Lovegrove, W.; Lucey, A.; Lukaschuk, E.; Lye, A.; Lynch, C.; MacDonald, S.; MacGowan, G.; Macharia, I.; Mackie, J.; Macliver, L.; Madathil, S.; Madzamba, G.; Magee, N.; Magtoto, M.M.; Mairs, N.; Majeed, N.; Major, E.; Malein, F.; Malim, M.; Mallison, G.; Mandal, S.; Mangion, K.; Manisty, C.; Manley, R.; March, K.; Marciniak, S.; Marino, P.; Mariveles, M.; Marouzet, E.; Marsh, S.; Marshall, B.; Marshall, M.; Martin, J.; Martineau, A.; Martinez, L.M.; Maskell, N.; Matila, D.; Matimba-Mupaya, W.; Matthews, L.; Mbuyisa, A.; McAdoo, S.; Weir McCall, J.; McAllister-Williams, H.; McArdle, A.; McArdle, P.; McAulay, D.; McCormick, J.; McCormick, W.; McCourt, P.; McGarvey, L.; McGee, C.; Mcgee, K.; McGinness, J.; McGlynn, K.; McGovern, A.; McGuinness, H.; McInnes, I.B.; McIntosh, J.; McIvor, E.; McIvor, K.; McLeavey, L.; McMahon, A.; McMahon, M.J.; McMorrow, L.; Mcnally, T.; McNarry, M.; McNeill, J.; McQueen, A.; McShane, H.; Mears, C.; Megson, C.; Megson, S.; Mehta, P.; Meiring, J.; Melling, L.; Mencias, M.; Menzies, D.; Merida, Morillas, M.; Michael, A.; Milligan, L.; Miller, C.; Mills, C.; Mills, N.L.; Milner, L.; Misra, S.; Mitchell, J.; Mohamed, A.; Mohamed, N.; Mohammed, S.; Molyneaux, P.L.; Monteiro, W.; Moriera, S.; Morley, A.; Morrison, L.; Morriss, R.; Morrow, A.; Moss, A.J.; Moss, P.; Motohashi, K.; Msimanga, N.; Mukaetova-Ladinska, E.; Munawar, U.; Murira, J.; Nanda, U.; Nassa, H.; Nasseri, M.; Neal, A.; Needham, R.; Neill, P.; Newell, H.; Newman, T.; Newton-Cox, A.; Nicholson, T.; Nicoll, D.; Nolan, C.M.; Noonan, M.J.; Norman, C.; Novotny, P.; Nunag, J.; Nwafor, L.; Nwanguma, U.; Nyaboko, J.; O’Donnell, K.; O’Brien, C.; O’Brien, L.; O’Regan, D.; Odell, N.; Ogg, G.; Olaosebikan, O.; Oliver, C.; Omar, Z.; Orriss-Dib, L.; Osborne, L.; Osbourne, R.; Ostermann, M.; Overton, C.; Owen, J.; Oxton, J.; Pack, J.; Pacpaco, E.; Paddick, S.; Painter, S.; Pakzad, A.; Palmer, S.; Papineni, P.; Paques, K.; Paradowski, K.; Pareek, M.; Parfrey, H.; Pariante, C.; Parker, S.; Parkes, M.; Parmar, J.; Patale, S.; Patel, B.; Patel, M.; Patel, S.; Pattenadk, D.; Pavlides, M.; Payne, S.; Pearce, L.; Pearl, J.E.; Peckham, D.; Pendlebury, J.; Peng, Y.; Pennington, C.; Peralta, I.; Perkins, E.; Peterkin, Z.; Peto, T.; Petousi, N.; Petrie, J.; Phipps, J.; Pimm, J.; Piper, Hanley, K.; Pius, R.; Plant, H.; Plein, S.; Plekhanova, T.; Plowright, M.; Polgar, O.; Poll, L.; Porter, J.; Portukhay, S.; Powell, N.; Prabhu, A.; Pratt, J.; Price, A.; Price, C.; Price, C.; Price, D.; Price, L.; Price, L.; Prickett, A.; Propescu, J.; Pugmire, S.; Quaid, S.; Quigley, J.; Qureshi, H.; Qureshi, I.N.; Radhakrishnan, K.; Ralser, M.; Ramos, A.; Ramos, H.; Rangeley, J.; Rangelov, B.; Ratcliffe, L.; Ravencroft, P.; Reddington, A.; Reddy, R.; Redfearn, H.; Redwood, D.; Reed, A.; Rees, M.; Rees, T.; Regan, K.; Reynolds, W.; Ribeiro, C.; Richards, A.; Richardson, E.; Rivera Ortega, P.; Roberts, K.; Robertson, E.; Robinson, E.; Robinson, L.; Roche, L.; Roddis, C.; Rodger, J.; Ross, A.; Ross, G.; Rossdale, J.; Rostron, A.; Rowe, A.; Rowland, A.; Rowland, J.; Roy, K.; Roy, M.; Rudan, I.; Russell, R.; Russell, E.; Saalmink, G.; Sabit, R.; Sage, E.K.; Samakomva, T.; Samani, N.; Sampson, C.; Samuel, K.; Samuel, R.; Sanderson, A.; Sapey, E.; Saralaya, D.; Sargant, J.; Sarginson, C.; Sass, T.; Sattar, N.; Saunders, K.; Saunders, P.; Saunders, L.C.; Savill, H.; Saxon, W.; Sayer, A.; Schronce, J.; Schwaeble, W.; Scott, K.; Selby, N.; Sewell, T.A.; Shah, K.; Shah, P.; Shankar Hari, M.; Sharma, M.; Sharpe, C.; Sharpe, M.; Shashaa, S.; Shaw, A.; Shaw, K.; Shaw, V.; Shelton, S.; Shenton, L.; Shevket, K.; Short, J.; Siddique, S.; Siddiqui, S.; Sidebottom, J.; Sigfrid, L.; Simons, G.; Simpson, J.; Simpson, N.; Singh, C.; Singh, S.; Sissons, D.; Skeemer, J.; Slack, K.; Smith, A.; Smith, D.; Smith, S.; Smith, J.; Smith, L.; Soares, M.; Solano, T.S.; Solly, R.; Solstice, A.R.; Soulsby, T.; Southern, D.; Sowter, D.; Spears, M.; Spencer, L.G.; Speranza, F.; Stadon, L.; Stanel, S.; Steele, N.; Steiner, M.; Stensel, D.; Stephens, G.; Stephenson, L.; Stern, M.; Stewart, I.; Stimpson, R.; Stockdale, S.; Stockley, J.; Stoker, W.; Stone, R.; Storrar, W.; Storrie, A.; Storton, K.; Stringer, E.; Strong Sheldrake, S.; Stroud, N.; Subbe, C.; Sudlow, C.L.; Suleiman, Z.; Summers, C.; Summersgill, C.; Sutherland, D.; Sykes, D.L.; Sykes, R.; Talbot, N.; Tan, A.L.; Tarusan, L.; Tavoukjian, V.; Taylor, A.; Taylor, C.; Taylor, J.; Te, A.; Tedd, H.; Tee, C.J.; Teixeira, J.; Tench, H.; Terry, S.; Thackray Nocera, S.; Thaivalappil, F.; Thamu, B.; Thickett, D.; Thomas, C.; Thomas, S.; Thomas, A.K.; Thomas Woods, T.; Thompson, T.; Thompson, A A R.; Thornton, T.; Tilley, J.; Tinker, N.; Tiongson, G.F.; Tobin, M.; Tomlinson, J.; Tong, C.; Touyz, R.; Tripp, K.A.; Tunnicliffe, E.; Turnbull, A.; Turner, E.; Turner, S.; Turner, V.; Turner, K.; Turney, S.; Turtle, L.; Turton, H.; Ugoji, J.; Ugwuoke, R.; Upthegrove, R.; Valabhji, J.; Ventura, M.; Vere, J.; Vickers, C.; Vinson, B.; Wade, E.; Wade, P.; Wainwright, T.; Wajero, L.O.; Walder, S.; Walker, S.; Walker, S.; Wall, E.; Wallis, T.; Walmsley, S.; Walsh, J.A.; Walsh, S.; Warburton, L.; Ward, T.J.C.; Warwick, K.; Wassall, H.; Waterson, S.; Watson, E.; Watson, L.; Watson, J.; Welch, C.; Welch, H.; Welsh, B.; Wessely, S.; West, S.; Weston, H.; Wheeler, H.; White, S.; Whitehead, V.; Whitney, J.; Whittaker, S.; Whittam, B.; Whitworth, V.; Wight, A.; Wild, J.; Wilkins, M.; Wilkinson, D.; Williams, N.; Williams, N.; Williams, J.; Williams Howard, S.A.; Willicombe, M.; Willis, G.; Willoughby, J.; Wilson, A.; Wilson, D.; Wilson, I.; Window, N.; Witham, M.; Wolf Roberts, R.; Wood, C.; Woodhead, F.; Woods, J.; Wormleighton, J.; Worsley, J.; Wraith, D.; Wrey, Brown, C.; Wright, C.; Wright, L.; Wright, S.; Wyles, J.; Wynter, I.; Xu, M.; Yasmin, N.; Yasmin, S.; Yates, T.; Yip, K.P.; Young, B.; Young, S.; Young, A.; Yousuf, A.J.; Zawia, A.; Zeidan, L.; Zhao, B.; Zongo, O. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir. Med., 2022, 10(8), 761-775.
[http://dx.doi.org/10.1016/S2213-2600(22)00127-8] [PMID: 35472304]

Bridger Staatz, C.; Bann, D.; Ploubidis, G.B.; Goodman, A.; Silverwood, R.J. Age of first overweight and obesity, COVID-19 and long COVID in two british birth cohorts. J. Epidemiol. Glob. Health, 2023, 13(1), 140-153.
[http://dx.doi.org/10.1007/s44197-023-00093-5] [PMID: 36811824]

Huerne, K.; Filion, K.B.; Grad, R.; Ernst, P.; Gershon, A.S.; Eisenberg, M.J. Epidemiological and clinical perspectives of long COVID syndrome. Am. J. Med. Open, 2023, 9, 100033.
[http://dx.doi.org/10.1016/j.ajmo.2023.100033] [PMID: 36685609]

Antonelli, M.; Pujol, J.C.; Spector, T.D.; Ourselin, S.; Steves, C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet, 2022, 399(10343), 2263-2264.
[http://dx.doi.org/10.1016/S0140-6736(22)00941-2] [PMID: 35717982]